BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
Topic

Merck & Co

US to procure additional 100mn doses of J&J COVID-19 vaccine

US to procure additional 100mn doses of J&J COVID-19 vaccine

Published 10 Mar, 2021 08:10pm
  • President Joe Biden will make the announcement at a meeting with the chief executives of J&J and Merck & Co later in the day, the official said. Merck has agreed to partner with J&J to produce its vaccine.
  • J&J's manufacturing has been slower than expected, and the company was not expected to be able to deliver any doses of its vaccine this week. It is expected to resume shipments later in March.
Merck's Kenneth Frazier to step down as CEO

Merck's Kenneth Frazier to step down as CEO

Published 04 Feb, 2021 06:02pm
  • The company reported a fourth-quarter loss of $2.09 billion, or 83 cents per share, compared with a profit of $2.36 billion or 92 cents per share, a year earlier.
  • Frazier, 66, was set to retire in 2019, but the company scrapped a policy requiring CEOs to retire at the age of 65.
Johnson & Johnson promises vaccine data ‘soon’

Johnson & Johnson promises vaccine data ‘soon’

Published 26 Jan, 2021 05:02pm
*Data from Johnson & Johnson's single-dose COVID-19 shot is expected this month, with global hopes to battle the virus riding on multiple vaccines to ensure adequate supply. * In the latest setback to the effort, rival Merck & Co said on Monday it was discontinuing development of both its COVID-19 vaccines.
Merck ends COVID vaccine program, cites inferior immune responses

Merck ends COVID vaccine program, cites inferior immune responses

Published 25 Jan, 2021 06:21pm
  • The company will record a pre-tax discontinuation charge in the fourth quarter for vaccine candidate V591.
  • The announcement is a setback to the fight against the pandemic and comes a month after Sanofi and GlaxoSmithKline delayed launch of their shot to late 2021.
Loading...